<DOC>
	<DOCNO>NCT02086695</DOCNO>
	<brief_summary>The early detection BVZ Sunitinib mediate cardiotoxicity use cardiac biomarkers novel Transthoracic Echocardiogram ( TTE ) technique may allow one adjust treatment and/or administer prophylactic cardioprotective agent , prior development irreversible cardiac dysfunction . We hypothesize cardiac biomarkers , TVI/strain-derived index able accurately detect subtle cardiac injury time conventional Left Ventricular Ejection Fraction ( LVEF ) remain normal BVZ Sunitinib mediate cardiotoxicity . Additionally , hypothesize Endothelial Function Test ( EndoPAT ) test detect early BVZ Sunitinib mediate endothelial dysfunction .</brief_summary>
	<brief_title>Early Detection Broken Hearts Cancer Patients</brief_title>
	<detailed_description>A total 100 individual ( 50 receive BVZ 50 receive Sunitinib ) prospectively enrol . ( 80 Mayo Clinic [ 80 receive BVZ , Sunitinib , Pazopanib ] 20 St. Boniface General Hospital ( SBGH ) ) . Patients receive either BVZ 5mg/kg iv , Sunitinib 50 mg po daily , Pazopanib advance Metastatic carcinoma screen potential eligibility study . For metastatic renal cancer treatment , Sunitinib dose ( oral ) 50 mg day 4 week follow two week period . The six week cycle repeat . In case toxicity observe dose , 25 % reduction daily dose `` '' period perform ( 37.5 mg ) . Patients study 7 time point : ) Baseline ; ii ) Day 1 ; iii ) Day 5 ; iv ) 4-6 week ; v ) 3 month ; vi ) 6 month initiation drug ( BVZ Sunitinib ) ; vii ) 12 month initiation BVZ drug ( Figure 1 ) . Three visit ( baseline , 4-6 week , 3 month ) consider part standard clinical care , four visit research . At visit , addition standard care provide Oncologist , blood drawn measure high sensitivity troponin-T ( hsTnT ) Natriuretic-proBNP . The patient also undergo TTE tissue velocity imaging ( TVI ) , strain left ventricular opacification ( LVO ) myocardial perfusion time point . EndoPAT test also perform baseline , 3 month . The baseline , 4-6 week , 3 month visit part standard clinical care followup .</detailed_description>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>1 . Patients advance cancer 2 . Treatment plan include BVZ , Sunitinib , Pazopanib 3 . Ages 18 90 year old Left Ventricular EF &lt; 50 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chemotherapy</keyword>
	<keyword>Cardiotoxicity</keyword>
</DOC>